Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NUS
|
Ryan S Napierski
President and CEO |
SELL
Open market or private sale
|
Direct | 10,156 Reduced 12.14% |
$600,423
$59.12 p/Share
|
Jan 20
2021 |
|
AMK
|
Gary G. Zyla
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,756 Reduced 1.62% |
$68,928
$25.01 p/Share
|
Jan 20
2021 |
|
AMK
|
Michael Kim
CEO and President |
SELL
Open market or private sale
|
Direct | 3,479 Reduced 1.17% |
$87,010
$25.01 p/Share
|
Jan 20
2021 |
|
SRI
|
Jonathan B De Gaynor
President and CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.4% |
$302,300
$30.23 p/Share
|
Jan 20
2021 |
|
VAPO
|
Gregoire Ramade
SVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 8.84% |
$63,840
$31.92 p/Share
|
Jan 20
2021 |
|
NCNO
|
Salesforce.Com, Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 17,349 Reduced 0.08% |
$1,243,923
$71.7 p/Share
|
Jan 20
2021 |
|
ACN
|
Kathleen R Mc Clure
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 724 Reduced 2.94% |
$187,806
$259.4 p/Share
|
Jan 20
2021 |
|
HGEN
|
Nomis Bay Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.04% |
$45,925
$18.37 p/Share
|
Jan 20
2021 |
|
MA
|
Foundation Mastercard |
SELL
Open market or private sale
|
Direct | 57,198 Reduced 0.05% |
$19,184,209
$335.4 p/Share
|
Jan 20
2021 |
|
META
|
Jennifer Newstead
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 97 Reduced 8.46% |
$26,093
$269.0 p/Share
|
Jan 20
2021 |
|
DELL
|
Jeffrey W Clarke
COO & Vice Chairman |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 20.64% |
$7,649,000
$76.49 p/Share
|
Jan 20
2021 |
|
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 14,400 Reduced 0.16% |
$990,720
$68.8 p/Share
|
Jan 20
2021 |
|
SNAP
|
Jeremi Gorman
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 15,792 Reduced 0.78% |
$799,865
$50.65 p/Share
|
Jan 20
2021 |
|
SNAP
|
Jerry James Hunter
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 7,609 Reduced 1.66% |
$384,483
$50.53 p/Share
|
Jan 20
2021 |
|
NET
|
Matthew Prince
CEO & Board Co-Chair |
SELL
Open market or private sale
|
Indirect | 52,385 Reduced 53.17% |
$4,340,621
$82.86 p/Share
|
Jan 20
2021 |
|
CCL
|
David Bernstein
CFO & CAO |
SELL
Open market or private sale
|
Direct | 24,296 Reduced 13.79% |
$509,730
$20.98 p/Share
|
Jan 20
2021 |
|
CUK
|
David Bernstein
CFO & CAO |
SELL
Open market or private sale
|
Direct | 24,296 Reduced 13.79% |
$509,730
$20.98 p/Share
|
Jan 20
2021 |
|
PII
|
Robert Paul Mack
CFO, EVP - Finance + Corp Dev |
SELL
Open market or private sale
|
Direct | 9,250 Reduced 46.08% |
$1,096,032
$118.49 p/Share
|
Jan 20
2021 |
|
GH
|
Helmy Eltoukhy
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 167,663 Reduced 5.36% |
$27,552,061
$164.33 p/Share
|
Jan 20
2021 |
|
GH
|
Helmy Eltoukhy
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 44,528 Reduced 1.42% |
$7,317,731
$164.34 p/Share
|
Jan 20
2021 |
|
TWST
|
Emily M. Leproust
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.25% |
$1,051,000
$210.2 p/Share
|
Jan 20
2021 |
|
ICFI
|
John Wasson
CEO & President |
SELL
Open market or private sale
|
Direct | 3,329 Reduced 4.28% |
$266,320
$80.0 p/Share
|
Jan 20
2021 |
|
PING
|
Adriana Zenia Carpenter
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 6.07% |
$78,750
$31.5 p/Share
|
Jan 20
2021 |
|
SWTX
|
Saqib Islam
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,199 Reduced 0.18% |
$173,171
$78.75 p/Share
|
Jan 20
2021 |
|
XPEL
|
Richard K. Crumly
Director |
SELL
Open market or private sale
|
Indirect | 24,000 Reduced 20.07% |
$1,252,800
$52.2 p/Share
|
Jan 20
2021 |
|
ADPT
|
Harlan S Robins
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 98.66% |
$3,374,000
$67.48 p/Share
|
Jan 20
2021 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$1,012,050
$67.47 p/Share
|
Jan 20
2021 |
|
EXTR
|
Edward Meyercord
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 14,785 Reduced 2.62% |
$118,280
$8.0 p/Share
|
Jan 20
2021 |
|
ALEC
|
Robert Paul
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 8,567 Reduced 3.85% |
$154,206
$18.0 p/Share
|
Jan 20
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.68% |
$265,200
$8.84 p/Share
|
Jan 20
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,148 Reduced 0.64% |
$125,068
$8.84 p/Share
|
Jan 20
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 15,852 Reduced 0.7% |
$140,132
$8.84 p/Share
|
Jan 20
2021 |
|
COLL
|
Shirley R. Kuhlmann
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 6,081 Reduced 5.55% |
$148,680
$24.45 p/Share
|
Jan 20
2021 |
|
BLFS
|
Walter Villiger
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 29,182 Reduced 0.85% |
$1,197,337
$41.03 p/Share
|
Jan 20
2021 |
|
RMNI
|
Kevin Maddock
EVP,ChiefRecurringRev.Officer |
SELL
Open market or private sale
|
Direct | 27,500 Reduced 39.88% |
$203,225
$7.39 p/Share
|
Jan 20
2021 |
|
SFIX
|
Katrina Lake
Director |
SELL
Open market or private sale
|
Indirect | 43,775 Reduced 78.92% |
$3,671,847
$83.88 p/Share
|
Jan 20
2021 |
|
BCYC
|
Kevin Lee
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 1,185 Reduced 0.46% |
$38,062
$32.12 p/Share
|
Jan 20
2021 |
|
QUOT
|
Steven R. Boal
Director |
SELL
Open market or private sale
|
Direct | 3,498 Reduced 0.1% |
$35,085
$10.03 p/Share
|
Jan 20
2021 |
|
EVER
|
Jayme Mendal
CEO and President |
SELL
Open market or private sale
|
Direct | 309 Reduced 0.15% |
$12,363
$40.01 p/Share
|
Jan 20
2021 |
|
LQDA
|
Eshelman Ventures, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 53,405 Reduced 0.9% |
$157,545
$2.95 p/Share
|
Jan 20
2021 |
|
GTHX
|
Mark A. Velleca |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 21.28% |
$215,100
$21.51 p/Share
|
Jan 20
2021 |
|
GRTS
|
Raphael Rousseau
Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 100.0% |
$250,700
$25.07 p/Share
|
Jan 20
2021 |
|
XGN
|
Hunt Holdings Limited Partnership
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 2.15% |
$483,900
$16.13 p/Share
|
Jan 20
2021 |
|
SALM
|
David Evans
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 5,102 Reduced 100.0% |
$8,418
$1.65 p/Share
|
Jan 20
2021 |
|
APLT
|
Riccardo Perfetti
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 465 Reduced 100.0% |
$9,802
$21.08 p/Share
|
Jan 20
2021 |
|
OPXS
|
Ephraim G Fields
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 26,776 Reduced 2.29% |
$53,820
$2.01 p/Share
|
Jan 20
2021 |
|
MDLA
|
Leslie Stretch
President and CEO |
SELL
Open market or private sale
|
Direct | 31,686 Reduced 2.58% |
$1,240,824
$39.16 p/Share
|
Jan 20
2021 |
|
PCVX
|
Jim Wassil
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 15.48% |
$76,500
$25.5 p/Share
|
Jan 20
2021 |
|
EVBG
|
Elliot J. Mark
SVP & General Counsel |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 8.99% |
$140,480
$140.48 p/Share
|
Jan 20
2021 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 44,750 Reduced 27.78% |
$11,951,829
$267.08 p/Share
|
Jan 20
2021 |